Full video transcriptClick to expand
Auto-generated transcript of @braedenmillerfit's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00TRT starting dose.
- 0:01Males 100 to 200 milligrams, females 2 to 5 milligrams a week.
- 0:05How often should you be pinning?
- 0:06Males as much as possible, therefore,
- 0:08I'm a huge fan of daily injections.
- 0:10Females, same thing, as often as possible.
- 0:12The problem is we're not really gonna be able to get
- 0:14a very, very low dose test.
- 0:16So that being said, I would say two times a week
- 0:18with a long-aster test will be great.
- 0:20How often should I get blood work?
- 0:21Males, minimum quarterly, females,
- 0:23I would say the exact same thing, quarterly if you can.
- 0:25The more we can keep an eye on our internal health,
- 0:27the better and healthier we're gonna be
- 0:28injectable or creams.
- 0:30Easy.
- 0:31Males, injectable.
- 0:32Ladies, injectables.
- 0:34A lot of times you're gonna be recommended creams.
- 0:35It's gonna be very hard to have a consistent
- 0:37stable absorption rate where you're getting
- 0:39the same amount of test all the time.
- 0:40Inject it, you know what you're taking.
- 0:42Way more stable levels.
- 0:43Should I be taking an AI?
- 0:45Males, TRT, absolutely not.
- 0:47It's not necessary.
- 0:48Clinics are prescribing this to make fucking money.
- 0:50Women, absolutely not.
- 0:51There is no world where you need an AI
- 0:53when you're running TRT.
TRT for men and women: what fitness influencers get wrong
Quick answer
Testosterone replacement therapy for hypogonadism is FDA-approved for men with confirmed low testosterone via two morning lab draws, but female testosterone therapy remains off-label in the United States, with dosing and monitoring protocols varying widely across providers. The creator's preference for injectable testosterone over transdermal delivery reflects a real pharmacokinetic advantage in reducing peak-to-trough variability, though individual patient factors including needle phobia, skin sensitivity, and lifestyle should guide delivery method selection. AI use on TRT is genuinely over-prescribed in some clinical settings, but patient-specific aromatase activity means a blanket prohibition is not supported by current evidence.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For TRT for men and women: what fitness influencers get wrong, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
TRT for men and women: what fitness influencers get wrong is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "TRT for men and women: what fitness influencers get wrong" from Coach B. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Testosterone replacement therapy for hypogonadism is FDA-approved for men with confirmed low testosterone via two morning lab draws, but female testosterone therapy remains off-label in the United States, with dosing and monitoring protocols varying widely across providers.
The reason this review is not generic is the source wording and the canonical claim label "trt male female trt guide." In this clip, the useful excerpt is: "TRT starting dose." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Testosterone replacement therapy for hypogonadism is FDA-approved for men with confirmed low testosterone via two morning lab draws, but female testosterone therapy remains off-label in the United States, with dosing and monitoring protocols varying widely across providers.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Testosterone replacement therapy for hypogonadism is FDA-approved for men with confirmed low testosterone via two morning lab draws, but female testosterone therapy remains off-label in the United States, with dosing and monitoring protocols varying widely across providers. The creator's preference for injectable testosterone over transdermal delivery reflects a real pharmacokinetic advantage in reducing peak-to-trough variability, though individual patient factors including needle phobia, skin sensitivity, and lifestyle should guide delivery method selection. AI use on TRT is genuinely over-prescribed in some clinical settings, but patient-specific aromatase activity means a blanket prohibition is not supported by current evidence.
- Endocrine Society guidelines recommend confirming low testosterone with two separate morning blood draws before initiating TRT, a step the creator did not mention.
- More frequent testosterone injections do reduce peak-to-trough hormone swings, per pharmacokinetic data, but daily self-injection requires training and adherence most patients find challenging.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Endocrine Society guidelines recommend confirming low testosterone with two separate morning blood draws before initiating TRT, a step the creator did not mention.
- More frequent testosterone injections do reduce peak-to-trough hormone swings, per pharmacokinetic data, but daily self-injection requires training and adherence most patients find challenging.
- Transdermal testosterone absorption varies by up to 30 to 40 percent between individuals according to Swerdloff et al. (2000), which supports the creator's skepticism of creams as a delivery method for precise dosing.
- Shoskes et al. (2016) found that some men on TRT develop elevated estradiol requiring clinical intervention, meaning the claim that AIs are never needed is not supported by evidence.
- Female testosterone therapy remains off-label in the US, and the evidence base for dosing, monitoring, and long-term safety is significantly thinner than for male TRT.
- Hematocrit elevation is one of the most common and serious side effects of testosterone therapy in men and should be monitored at every blood work interval, a point absent from this video.
- No TRT protocol should be determined by social media content. Labs, symptoms, and a licensed clinician's assessment are the only appropriate basis for prescribing decisions.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @braedenmillerfit actually say?
The creator laid out a male and female TRT guide covering starting doses, injection frequency, blood work schedules, delivery method preferences, and aromatase inhibitor (AI) use. For males, he suggested 100 to 200 milligrams per week and said daily injections are ideal. For females, he recommended 2 to 5 milligrams per week with twice-weekly injections of a long-ester testosterone. He called creams unreliable because of inconsistent absorption, pushed injectables for both sexes, argued quarterly blood work is the minimum, and made the sweeping claim that AIs are never necessary on TRT, adding that clinics prescribe them purely "to make fucking money."
That last point is where things get complicated. The rest of the guide is a reasonable lay summary of common clinical practice, but some of it blurs the line between general population trends and individual patient needs.
Does the science back this up?
Partially. The preference for injections over transdermal delivery has legitimate support, but the blanket AI dismissal does not hold up under scrutiny for every patient.
On injection frequency, the pharmacokinetic case is real. Shorter injection intervals with testosterone cypionate or enanthate produce smaller peak-to-trough swings, which many patients report feeling better on. A 2020 review in the Journal of Clinical Endocrinology and Metabolism (Ramasamy et al.) confirmed that more frequent dosing reduces supraphysiologic peaks, a genuine clinical concern.
On transdermal absorption variability, the creator is largely correct. Gel absorption varies by skin site, hydration, and individual physiology. Studies including Swerdloff et al. (2000, Journal of Clinical Endocrinology and Metabolism) documented meaningful inter-individual variation in gel absorption, which complicates dose titration.
On AIs, however, blanket dismissal is not defensible. Some men on TRT aromatize testosterone to estradiol at rates that produce symptomatic hyperestrogenism, including gynecomastia and fluid retention. A subset of patients genuinely benefit from low-dose AI use under clinical supervision, per Shoskes et al. (2016, Translational Andrology and Urology).
What did they get wrong (or right)?
He got the injection frequency argument right in spirit. He got the cream criticism mostly right. He got the AI blanket ban wrong, and that is the most clinically consequential error in the video.
The claim that "there is no world where you need an AI when you're running TRT" is too absolute. While over-prescription of AIs is a documented problem in cash-pay hormone clinics, the correct answer is that most patients on physiologic TRT doses do not need an AI, but some do. Hammering that distinction matters because a patient with true symptomatic hyperestrogenism who watches this video may dismiss a legitimate clinical tool.
The female dosing range of 2 to 5 milligrams per week is broadly consistent with published clinical guidance from organizations like the Endocrine Society, though the evidence base for female testosterone therapy remains thinner than for males, and individual titration is important. His female AI dismissal is more defensible since exogenous testosterone at these doses rarely produces estradiol excess requiring pharmacologic intervention in women.
The quarterly blood work recommendation is reasonable as a minimum but conservative clinicians often recommend more frequent monitoring in the first 6 to 12 months of therapy.
What should you actually know?
TRT is not a one-size protocol, and anyone telling you there is a single right answer for all patients is oversimplifying. That said, the creator gets more right than wrong, which puts him ahead of most TikTok hormone content.
If you are considering TRT, a few things are worth knowing. First, baseline labs before starting are non-negotiable, including total testosterone, free testosterone, LH, FSH, estradiol, hematocrit, and PSA for men. Second, whether you need an AI is a question your bloodwork and symptoms should answer, not a blanket policy. Third, delivery method should match your lifestyle and absorption profile, not a content creator's preference. Fourth, female testosterone therapy remains an area where clinical guidance is still evolving, and the evidence base is weaker than many hormone optimization providers acknowledge.
FormBlends connects patients with licensed clinicians who review your labs before any prescribing decision. No protocol is determined by what a TikTok video recommends.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Coach B · TikTok creator
37.9K views on this video
Male & female TRT guide
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about endocrine society guidelines recommend confirming low testosterone with two separate?
Endocrine Society guidelines recommend confirming low testosterone with two separate morning blood draws before initiating TRT, a step the creator did not mention.
What does the video say about more frequent testosterone injections do reduce peak-to-trough hormone swings, per?
More frequent testosterone injections do reduce peak-to-trough hormone swings, per pharmacokinetic data, but daily self-injection requires training and adherence most patients find challenging.
What does the video say about transdermal testosterone absorption varies by up to 30 to 40?
Transdermal testosterone absorption varies by up to 30 to 40 percent between individuals according to Swerdloff et al. (2000), which supports the creator's skepticism of creams as a delivery method for precise dosing.
What does the video say about shoskes et al. (2016) found?
Shoskes et al. (2016) found that some men on TRT develop elevated estradiol requiring clinical intervention, meaning the claim that AIs are never needed is not supported by evidence.
What does the video say about female testosterone therapy remains off-label in the us,?
Female testosterone therapy remains off-label in the US, and the evidence base for dosing, monitoring, and long-term safety is significantly thinner than for male TRT.
What does the video say about hematocrit elevation?
Hematocrit elevation is one of the most common and serious side effects of testosterone therapy in men and should be monitored at every blood work interval, a point absent from this video.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Coach B, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.